Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Brain Research Bulletin

• Publication date

  2001-11-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0361-9230(01)00623-2PMID 11750789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour

  2004cited by this paper
• Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone

  2004cited by this paper
• The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during Endocytosis* 210

  2001cited by this paper
• Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells.

  2001cited by this paper
• Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq.

  2000cited by this paper
• Downregulation of G protein-coupled receptors.

  2000cited by this paper
• Selective Regulation of Gq Signaling by G Protein-Coupled Receptor Kinase 2: Direct Interaction of Kinase N Terminus with Activated Gαq

  2000cited by this paper
• The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits.

  2000cited by this paper
• The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?

  2000cited by this paper
• Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.

  1999cited by this paper
• Structure and Function of the Third Intracellular Loop of the 5‐Hydroxytryptamine2A Receptor: The Third Intracellular Loop Is α‐Helical and Binds Purified Arrestins

  1999cited by this paper
• Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.

  1999cited by this paper
• Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line.

  1999cited by this paper
• The 5-HT3B subunit is a major determinant of serotonin-receptor function

  1999cited by this paper
• Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure.

  1999cited by this paper
• 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.

  1998cited by this paper
• Molecular mechanisms of G protein-coupled receptor desensitization and resensitization.

  1998cited by this paper
• Role of Clathrin-mediated Endocytosis in Agonist-induced Down-regulation of the β2-Adrenergic Receptor*

  1998cited by this paper
• 霊長類大脳皮質の5‐ヒドロキシトリプタミン2Aセロトニン受容体 錐体細胞先端樹状突起での幻覚剤及び抗精神病剤の作用部位

  1998cited by this paper
• Agonist and Antagonist-Dependent Internalization of the Human Vasopressin V2Receptor☆

  1998cited by this paper
• Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor.

  1998cited by this paper
• Visualization of Agonist-induced Sequestration and Down-regulation of a Green Fluorescent Protein-tagged β2-Adrenergic Receptor*

  1998cited by this paper
• The role of receptor kinases and arrestins in G protein-coupled receptor regulation.

  1998cited by this paper
• Serotonergic Antagonist Effects on Trafficking of Serotonin 5‐HT2A Receptors in Vitro and in Vivo a

  1998cited by this paper
• G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse.

  1998cited by this paper
• The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis.

  1998cited by this paper
• Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.

  1998cited by this paper
• 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.

  1998cited by this paper
• Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation.

  1998cited by this paper
• Synergistic Regulation of β2-Adrenergic Receptor Sequestration: Intracellular Complement of β-Adrenergic Receptor Kinase and β-Arrestin Determine Kinetics of Internalization

  1997cited by this paper
• A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types.

  1997cited by this paper
• Arrestin/Clathrin Interaction

  1997cited by this paper
• Arrestin/Clathrin Interaction LOCALIZATION OF THE ARRESTIN BINDING LOCUS TO THE CLATHRIN TERMINAL DOMAIN*

  1997cited by this paper
• Arrestin/Clathrin Interaction LOCALIZATION OF THE CLATHRIN BINDING DOMAIN OF NONVISUAL ARRESTINS TO THE CARBOXYL TERMINUS*

  1997cited by this paper
• Serotonin 5‐HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex

  1997cited by this paper
• Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.

  1997cited by this paper
• Arrestin/Clathrin Interaction

  1997cited by this paper
• Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor.

  1997influential reference
• Endocytosis and recycling of G protein-coupled receptors.

  1997cited by this paper
• Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.

  1997cited by this paper
• Transcriptional regulation of the 5-HT2A receptor.

  1996cited by this paper
• Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.

  1996cited by this paper
• Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization

  1996cited by this paper
• The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain.

  1996influential reference
• Desensitization of G protein-coupled receptors.

  1996cited by this paper
• G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration.

  1996cited by this paper
• G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins.

  1996cited by this paper
• G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications.

  1996cited by this paper
• Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.

  1996cited by this paper
• Regulation of 5-HT2A receptor mRNA in P11 cells.

  1995cited by this paper
• Transcriptional regulation of the 5-HT2A receptor.

  1995cited by this paper
• Role of second messengers in agonist up-regulation of 5-HT2A (5-HT2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway.

  1995cited by this paper
• Differential Regulation of Rat 5-HT2A and 5-HT2C Receptors after Chronic Treatment with Clozapine, Chlorpromazine and Three Putative Atypical Antipsychotic Drugs

  1995influential reference
• Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain.

  1995cited by this paper
• Chronic buspirone treatment differentially regulates 5-HT1A and 5-HT2A receptor mRNA and binding sites in various regions of the rat hippocampus.

  1995cited by this paper
• Distinct Mechanisms Regulate 5-HT2 and Thrombin Receptor Desensitization (*)

  1995cited by this paper
• Loss of cortical serotonin2A signal transduction in senescent rats: reversal following inhibition of protein kinase C.

  1995cited by this paper
• 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation.

  1995influential reference
• Competitive antagonism by phenylglycine derivatives at type I metabotropic glutamate receptors.

  1994cited by this paper
• The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat.

  1994cited by this paper
• 5‐Hydroxytryptamine2 and β‐Adrenergic Receptor Regulation in Rat Brain Following Chronic Treatment with Desipramine and Fluoxetine Alone and in Combination

  1994cited by this paper
• Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex.

  1994cited by this paper
• EFFECTS OF REPEATED TREATMENT WITH FLUOXETINE AND CITALOPRAM, A 5‐HT UPTAKE INHIBITORS ON 5‐HT1A AND 5‐HT2 RECEPTORS IN THE RAT BRAIN.

  1994cited by this paper
• Regulation of Serotonin2A Receptors in Heterologous Expression Systems

  1994cited by this paper
• Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: modulation of transcription.

  1994cited by this paper
• Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C.

  1994cited by this paper
• Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.

  1993cited by this paper
• Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide.

  1993cited by this paper
• Paradoxical increase of 5-hydroxytryptamine2 receptors and 5-hydroxytryptamine2 receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine2 receptor stimulation.

  1993cited by this paper
• Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.

  1993influential reference
• Chronic Electroconvulsive Seizures Increase the Expression of Serotonin2 Receptor mRNA in Rat Frontal Cortex

  1993influential reference
• Homologous Desensitization of Serotonin 5‐HT2 Receptor‐Stimulated Intracellular Calcium Mobilization in C6BU‐1 Glioma Cells via a Mechanism Involving a Calmodulin Pathway

  1993cited by this paper
• Desensitization and down-regulation of 5-HT2 receptors in P11 cells.

  1991cited by this paper
• Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.

  1991cited by this paper
• Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.

  1991cited by this paper
• Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels.

  1991influential reference
• Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel.

  1991cited by this paper
• Gaps and peculiarities in 5-HT2 receptor studies.

  1990cited by this paper
• 5‐HT2 Receptors, Roles and Regulation

  1990cited by this paper
• Serotonin-induced acute desensitization of serotonin2 receptors in human platelets via a mechanism involving protein kinase C.

  1990cited by this paper
• Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms.

  1990cited by this paper
• Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells.

  1990cited by this paper
• beta-Arrestin: a protein that regulates beta-adrenergic receptor function.

  1990influential reference
• Imipramine and tetrabenazine: effects on monoamine receptor binding sites and phosphoinositide hydrolysis.

  1989cited by this paper
• Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

  1989cited by this paper
• [Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist].

  1989cited by this paper
• Chronic treatment with (+/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain.

  1989cited by this paper
• Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment.

  1989cited by this paper
• Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.

  1989influential reference
• Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain

  1989cited by this paper
• Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment.

  1988cited by this paper
• Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.

  1988cited by this paper
• Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment.

  1988cited by this paper
• Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5‐HT2 binding site changes

  1988influential reference
• Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.

  1986cited by this paper
• Differential Effect of Subchronic Treatment with Various Neuroleptic Agents on Serotonin2 Receptors in Rat Cerebral Cortex

  1986influential reference
• In vivo regulation of the serotonin-2 receptor in rat brain.

  1986cited by this paper
• 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.

  1986cited by this paper
• Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.

  1985cited by this paper
• Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.

  1985cited by this paper

• Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases.

  2025cites this paper
• Neurobiological Mechanisms of Electroconvulsive Therapy: Molecular Perspectives of Brain Stimulation

  2025cites this paper
• Alterations in resting-state brain activity patterns following antidepressant treatment: insights from a coordinate-based meta-analysis

  2025cites this paper
• Prefrontal 5-HT 2A receptors directly contribute to tic ontogeny: translational evidence

  2025cites this paper
• Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial

  2025cites this paper
• Agonism and Biased Signaling.

  2025cites this paper
• Prenatal paroxetine dysregulates monoamine homeostasis and affects placental hemodynamics in the rat fetoplacental unit.

  2025cites this paper
• Biased Signaling in Psychedelic Action.

  2025cites this paper
• 5-HT2A receptors: Pharmacology and functional selectivity

  2025cites this paper
• Neurochemical characterization of 5-HT2AR partial agonists with simultaneous PET-MRI

  2024cites this paper
• Involvement of serotonergic receptors in depressive processes and their modulation by β-arrestins: A review

  2024cites this paper
• Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression

  2024cites this paper
• Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model

  2024cites this paper
• The Impact of Antidepressants on Gut Microbiome and Depression Management

  2024cites this paper
• Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study

  2024cites this paper
• Modulation of TRPV1 on Odontoblast-like Cells Using Capsazepine-Loaded Nanogels

  2024cites this paper
• High-Throughput GPCRome Screen of Pollutants Reveals the Activity of Polychlorinated Biphenyls at Melatonin and Sphingosine-1-phosphate Receptors

  2024cites this paper
• Psychedelic therapy in depression and substance use disorders

  2024cites this paper
• LSD increases sleep duration the night after microdosing

  2024cites this paper
• JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

  2023cites this paper
• Assessing potential of psilocybin for depressive disorders

  2023cites this paper
• Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review

  2023cites this paper
• Drug–drug interactions involving classic psychedelics: A systematic review

  2023cites this paper
• Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication

  2023cites this paper
• Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential

  2023cites this paper
• Identification of 5-HT2A Receptor Signaling Pathways Responsible for Psychedelic Potential

  2023cites this paper
• Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals

  2022cites this paper
• Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies

  2022cites this paper
• Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice

  2022cites this paper
• Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice

  2022cites this paper
• A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear

  2021cites this paper
• Chronic heat stress delays immune system development and alters serotonin signaling in pre-weaned dairy calves

  2021cites this paper
• Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders

  2021cites this paper
• 5-HT Receptors and the Development of New Antidepressants

  2021cites this paper
• GRK2 Mediates β-Arrestin Interactions with 5-HT2 Receptors for JC Polyomavirus Endocytosis

  2021influential citation
• A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.

  2021cites this paper
• Biased agonism at histamine H1 receptor: desensitization, internalization and MAPK activation triggered by antihistamines.

  2021cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• Essential role of the C148 - C227 disulphide bridge in the human 5-HT2A homodimeric receptor.

  2020cites this paper
• A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.

  2020cites this paper
• A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.

  2020cites this paper
• Evidence of new-onset depression among persons with migraine after discontinuing antidepressants.

  2020cites this paper
• Biased signalling in platelet G-protein-coupled receptors.

  2020cites this paper
• Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

  2020cites this paper
• Constitutive activity of 5-HT receptors: Factual analysis.

  2020cites this paper
• 5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

  2020cites this paper
• Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans

  2020cites this paper
• Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities

  2020cites this paper
• A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain

  2020cites this paper
• Increasing serotonin bioavailability alters gene expression in peripheral leukocytes and lymphoid tissues of dairy calves

  2020cites this paper
• How Different Tissues Process Drug Response

  2019cites this paper
• Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling

  2019cites this paper
• Ligand‐directed serotonin 5‐HT2C receptor desensitization and sensitization

  2019cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin

  2019cites this paper
• Adaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT_2A receptors

  2019cites this paper
• Liraglutide, a GLP-1 Receptor Agonist, Which Decreases Hypothalamic 5-HT2A Receptor Expression, Reduces Appetite and Body Weight Independently of Serotonin Synthesis in Mice

  2018cites this paper
• Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders

  2018cites this paper
• 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives.

  2018cites this paper
• βArrestins: Ligand-Directed Regulators of 5-HT2A Receptor Trafficking and Signaling Events

  2018cites this paper
• Acute and chronic escitalopram alter EEG gamma oscillations differently: relevance to therapeutic effects

  2018cites this paper
• MAGI proteins can differentially regulate the signaling pathways of 5-HT2AR by enhancing receptor trafficking and PLC recruitment.

  2018cites this paper
• Chapter 2 Regulation of Intraneuronal Trafficking of G-Protein-Coupled Receptors by Neurotransmitters In Vivo

  2018cites this paper
• Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder

  2018cites this paper
• Effects of personality on the association between paroxetine plasma concentration and response

  2018cites this paper
• Inhibitor of Striatal-Enriched Protein Tyrosine Phosphatase, 8-(Trifluoromethyl)-1,2,3,4,5-Benzopentathiepin-6-Amine hydrochloride (TC-2153), Produces Antidepressant-Like Effect and Decreases Functional Activity and Protein Level of 5-HT2A Receptor in the Brain.

  2018cites this paper
• Serotonin receptor and dendritic plasticity in the spinal cord mediated by chronic serotonergic pharmacotherapy combined with exercise following complete SCI in the adult rat

  2018cites this paper
• 5-HT2A Receptors in the Central Nervous System

  2018cites this paper
• Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems

  2018cites this paper
• SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms.

  2018cites this paper
• Pharmacological Analysis in Favour of a Physiological Role for the Constitutive Activity of 5-HT 2A Receptors in Learning

  2018cites this paper
• PET studies on the mechanisms of action of antidepressant and antipsychotic drugs

  2017cites this paper
• Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs.

  2017cites this paper
• Running Title: Climate change in GPCR drug discovery?

  2017cites this paper
• Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus.

  2017cites this paper
• Developmental effects of antipsychotic drugs on serotonin receptor subtypes

  2017cites this paper
• Caractérisation neurochimique de la dyskinésie tardive dans un modèle primate non humain

  2017cites this paper
• Developing Serotonergic Antidepressants Acting on More Than the Serotonin Transporter

  2017cites this paper
• Estrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: A possible mechanism for menopausal depression.

  2017cites this paper
• G Protein‐Coupled Receptor Endosomal Signaling and Regulation of Neuronal Excitability and Stress Responses: Signaling Options and Lessons From the PAC1 Receptor

  2017cites this paper
• A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration

  2017cites this paper
• The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

  2017cites this paper
• Investigating the Mechanism of JC Polyomavirus Endocytosis

  2017influential citation
• Serotonin and brain function: a tale of two receptors

  2017cites this paper
• Inhibition of serotonin reuptake in the prepubertal rat ovary by fluoxetine and effects on ovarian functions.

  2016cites this paper
• A Convergence at the Serotonin-2A Receptor

  2016influential citation
• Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5.

  2016cites this paper
• 5-HT2A and mGlu2/3 receptor interactions: on their relevance to cognitive function and psychosis

  2016cites this paper
• Psychedelics

  2016cites this paper
• A Novel Mechanism for Nicotinic Acetylcholine Receptor Antagonist-Induced Cancer Cell Cytotoxicity

  2016cites this paper
• Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.

  2016cites this paper
• Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank.

  2016cites this paper
• Tumor Targeting, Pharmacokinetics and Biodistribution of a Near Infrared Fluorescent-labeled δ -Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5

  2016cites this paper
• Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors

  2016cites this paper
• The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors

  2015cites this paper
• Effect of ketamine on the regional cerebral blood flow and binding index of the 5-HT2A receptor radioligand 123I-R91150 in the canine brain

  2015cites this paper
• Physiological implications of biased signaling at histamine H2 receptors

  2015cites this paper
• Serotonin as a Regulator of the Hypothalamic-Pituitary-Interrenal Axis in Rainbow Trout (Oncorhynchus mykiss)

  2015cites this paper
• Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant Vortioxetine.

  2015cites this paper
• Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.

  2015cites this paper